Nexium Control given stamp of approval from consumers
Pfizer’s heartburn medication Nexium Control has been voted General Healthcare Product of the Year in an independent survey.
Product of the Year is the UK’s largest independent survey into product innovation, with more than 11,500 consumers taking part.
The initiative’s CEO Mike Nolan said he was delighted to give the proton pump inhibitor, which was reclassified as an over-the-counter (OTC) item in February 2015, his organisation’s “trusted stamp of approval”.
Nexium Control senior medical manager Kristie Sourial said greater accessibility to OTC medicines helps reduce pressure on the NHS, by allowing people to self-manage conditions.
Nexium Control works by blocking acid production in the stomach and is designed to provide up to 24 hours of protection against heartburn with one tablet a day.
A pack of seven tablets retails for £6.99, while a pack of 14 is £11.99.
To order, contact 0333 555 2526